InvestmentApr 23, 2026, 04:22 PM
Catheter Precision Closes $3.47M Series C-2 Preferred Stock Sale
AI Summary
Catheter Precision, Inc. announced the closing of its previously disclosed sale and issuance of Series C-2 Convertible Preferred Stock, raising $3.47 million in aggregate gross proceeds. The company issued 3,470 shares of the newly designated preferred stock, which is convertible into common stock at an initial price of $0.883 per share. This closing was contingent upon and followed the receipt of stockholder approval.
Key Highlights
- Catheter Precision closed the sale of Series C-2 Convertible Preferred Stock.
- Raised aggregate gross proceeds of $3,470,000.
- Issued 3,470 shares of Series C-2 Preferred Stock.
- Preferred stock convertible into common stock at $0.883 per share.
- Stockholder approval for conversion was obtained on April 15, 2026.
Price Impact
More from VTAK